In addition, invasiveness was also supported by E-cadherin loss and by the increased number of F-actin immunolabeled cells at the tumor invasive front and surrounding the lymphatic vessels, confirming this model as an effective model for studying the tumor early metastatic process, as previously established by Stacker and colleagues [19, 28–31]. The gene discussed is CDH1; the disease is neoplasm.